Case detection of selected inherited disorders through expanded newborn screening in the Philippines

Acta Medica Philippina

Volumn 46-47, Issue 4-1, 2012, Pages 24-29

  Padilla, Carmencita D ^a,b  

^a UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^b UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

Expanded newborn screening; Newborn screening; Philippine newborn screening program

Indexed keywords

EID: 84878566102     PISSN: 00016071     EISSN: 20949278     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. American Academy of Pediatrics, Newborn Screening Task Force. Serving the family from birth to the medical home: Newborn screening: a blueprint for the future. Pediatrics. 2000; 106(suppl):389-427.
2. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963; 32:338-43.
3. Padilla CD, Therrell BL. Screening newborns in the Asia-Pacific Region. In: Kumar D, ed. Genomics and Health in the Developing World. Oxford: Oxford University Press, Inc. 2012:764-781.
4. Padilla CD, Basilio J, Oliveros Y. Newborn Screening: Research to Policy. Acta Med Philipp. 2009; 43(2):6-14.
5. Padilla CD. Towards universal newborn screening in developing countries: obstacles and the way forward. Ann Acad Med Singapore. 2008; 37(12Suppl):6-4.
6. Newborn Screening Reference Center (NSRC). Program Briefer. [Online]. [cited 2012 Dec]. Available from www.newbornscreening.ph.
7. Schulze A, Lindner M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffman GF. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome and implications. Pediatrics. 2003; 111(6 Pt 1):1399-406. (Pubitemid 36682277)
8. Benson JM, Therrell BL Jr. History and current status of newborn screening for hemoglobinopathies. Semin Perinatol. 2010; 34(2):134-44.
9. Lorey F, Cunningham G, Vichinsky EP, et al. Universal newborn screening for Hb H disease in California. Genet Test. 2001; 5(2):93-100. (Pubitemid 32801824)
10. Hoppe CC. Newborn screening for hemoglobin disorders. Hemoglobin. 2011; 35(5-6):556-64.
11. Wilcken B, Wiley V, Hammond J, Carpenter K. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. N Engl J Med. 2003; 348(23):2304-12. (Pubitemid 36638104)
12. Bodamer OA, Hoffman GF, Lindner M. Expanded newborn screening in Europe 2007. J Inherit Metab Dis. 2007; 30(4):439-44.
13. Therrell BL, Adams J. Newborn screening in North America. J Inherit Metab Dis. 2007; 30(4):447-65. (Pubitemid 47377041)
14. Huang HP, Chu KL, Chien YH, et al. Tandem mass neonatal screening in Taiwan-Report from one center. J Formos Med Assoc. 2006; 105(11):882-6.
15. Han LS, Ye J, Qiu WJ, Gao XL, Wang Y, Gu XF. Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China: a four year report. J Inherit Metab Dis. 2007; 30(4):507-14. (Pubitemid 47377045)
16. Lindmer M, Hoffman GF, Matern D. Newborn screening for disorders of fatty acid oxidation: experience and recommendations from an expert meeting. J Inherit Metab Dis. 2010; 33(5):521-6.
17. Feuchtbaum L, Carter J, Dowray S, Currier RJ, Lorey F. Birth prevalence of disorders detectable through newborn screening by race/ethnicity. Genet Med. 2012; 14(11):937-45.
18. Watson MS. Current status of newborn screening: decision-making about the conditions to include in screening programs. Ment Retard Dev Disabil Res Rev. 2006; 12(4):230-5. (Pubitemid 46053448)
19. Loeber JG. Neonatal screening in Europe: the situation in 2004. J Inherit Metab Dis. 2007; 30(4):430-8. (Pubitemid 47377038)
20. Borrajo GJ. Newborn screening in Latin America at the beginning of the 21st century. J Inherit Metab Dis. 2007; 30(4):466-81. (Pubitemid 47377042)
21. Saadallah AA, Rashed MS. Newborn screening: experiences in the Middle East and North Africa. J Inherit Metab Dis. 2007; 30(4):482-9. (Pubitemid 47377043)
22. Wilcken B. Recent advances in newborn screening. J Inherit Metab Dis. 2007; 30(2):129-33. (Pubitemid 46487991)
23. Yamaguchi S. Newborn Screening in Japan: restructuring for the new era. Ann Acad Med Singapore. 2008; 37(12 Suppl ):13-5.
24. Gu X, Wang Z, Ye J, Han L, Qiu W. Newborn Screening in China: phenylketonuria, congenital hypothyroidism and expanded screening. Ann Acad Med Singapore. 2008; 37(12 Suppl):107-4.
25. Yoon HR, Lee KR, Kang S, et al. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clin Chim Acta. 2005; 354(1-2):167-80. (Pubitemid 40320688)
26. Han M, Jun SH, Song SH, Park KU, Kim JQ, Song J. Use of tandem mass spectrometry for newborn screening of 6 lysosomal storage disorders in a Korean population. Korean J Lab Med. 2011; 31(4):250-6.
27. Vichinsky E. Advances in the treatment of alpha-thalassemia. Blood Rev. 2012; 26 Suppl 1:S31-4.
28. Lal A, Goldrich ML, Haines DA, Azimi M, Singer ST, Vichinsky EP. Heterogeneity of hemoglobin H disease in childhood. N Engl J Med. 2011; 364(8):710-8.
29. Padilla CD, de la Paz EM. Genetic Services and testing in the Philippines. J Community Genet. 2012. DOI 10.1007/s12687-012-0102-1.
30. Feuchtbaum L, Cunningham G. Economic evaluation of tandem mass spectrometry screening in California. Pediatrics. 2006; 117(5 Pt 2):S280-6. (Pubitemid 46071315)
31. Venditti LN, Venditti CP, Berry GT, et al. Newborn screening by tandem mass spectrometry for medium-chain Acyl-CoA dehydrogenase deficiency: a cost-effectiveness analysis. Pediatrics. 2003; 112(5):1005-15. (Pubitemid 37339550)
32. Cipriano LE, Rupar CA, Zaric GS. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model. Value Health. 2007; 10(2):83-97. (Pubitemid 46481136)
33. Schoen EJ, Baker JC, Colby CJ, To TT. Cost-benefit analysis of universal tandem mass spectrometry for newborn screening. Pediatrics. 2002; 110(4):781-6.